DURHAM, N.C., June 24, 2019 (GLOBE NEWSWIRE) — Dova Pharmaceuticals, Inc. (DOVA) today announced the Company will present four abstracts with data from studies of avatrombopag in patients with chronic immune thrombocytopenia (ITP) at the 65th International Society on Thrombosis and Haemostasis (ISTH) Annual Scientific Meeting, being held July 6-10, 2019, in Melbourne, Australia.


Share this story, choose your platform!